According to the study by Talley et al, targeted drugs that inhibit eosinophil production or eosinophil-derived products, including leukotriene-receptor antagonists, humanized monoclonal antibody against inter-leukin-5 and histamine 1 and 2 antagonists, may be effective for the treatment of FD (13). This evidence concerns the gene IL5 and Fabry disease.